Article
Secondary anetoderma overlying schwannoma.
Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnapdong Songpagu.
Acta Dermato Venereologica (impact factor:
3.18).
02/2009;
89(2):219-20.
DOI:10.2340/00015555-0625
Source: PubMed
- Citations (7)
-
Cited In (0)
-
Article: Multiple cutaneous immunocytoma with secondary anetoderma: a report of two cases
[show abstract] [hide abstract]
ABSTRACT: We describe two men with multiple erythematous dermal nodules which were clinically and histologically consistent with a diagnosis of primary cutaneous immunocytoma. Both patients exhibited the very unusual feature of secondary anetoderma occurring in spontaneously resolving lesions. There is one previous report of anetoderma in association with a plasmacytoma. The pathogenesis remains unknown but release of cytokines such as interleukin-6 may be implicated.British Journal of Dermatology 06/2000; 143(1):165 - 170. · 3.67 Impact Factor -
Article: Anetodermic cutaneous changes overlying pilomatricomas.
[show abstract] [hide abstract]
ABSTRACT: Five pilomatricomas with anetodermic cutaneous changes and striae are presented. Pink to translucent, atrophic, scarlike skin that covers a typical pilomatricoma occurs most commonly in young women. Histopathologic examination showed an atrophic, edematous dermis with diminished, fragmented collagen fibers and absent elastic tissue.Journal of the American Academy of Dermatology 01/1992; 25(6 Pt 1):1072-6. · 3.99 Impact Factor -
Article: Anetoderma in a patient with juvenile xanthogranuloma.
British Journal of Dermatology 04/1999; 140(3):541-2. · 3.67 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.